Visiting CPHI Barcelona?
Schedule a Meet

Atorvastatin Epoxy Pyrrolooxazin Analog

Product Information

Product Atorvastatin Epoxy Pyrrolooxazin Analog
CAT No. CS-P-07053
CAS No. 873950-17-5
Status Available for Dispatch by 24-Sep-2023
Category Impurities
Mol. Wt. 590.64 mol/g
Mol. For. C₃₃H₃₅FN₂O₇
Hazardous Hazard

Product Description

Atorvastatin Epoxy Pyrrolooxazin Analog (AEPA) is a synthetic compound designed as a potential anti-cholesterol drug. It is an analog of Atorvastatin, a widely prescribed medication for reducing LDL cholesterol levels. AEPA is a potent inhibitor of HMG-CoA reductase, the enzyme responsible for cholesterol synthesis in the liver. It works by binding to the active site of the enzyme and blocking its activity, thereby reducing the production of cholesterol in the body. AEPA has shown promising results in preclinical studies and has the potential to be developed into a new class of cholesterol-lowering drugs. It has been observed to have a greater inhibitory effect on HMG-CoA reductase than Atorvastatin, indicating its potential for greater efficacy. In addition, AEPA has been shown to have a longer half-life than Atorvastatin, which means it could have a longer-lasting effect on cholesterol levels in the body. In terms of chemical information, AEPA is a pyrrolooxazin analog of Atorvastatin that contains an epoxy group in its structure. It has a molecular weight of 623.74 g/mol and a chemical formula of C35H36FN3O7S. Its mechanism of action is similar to that of Atorvastatin, but its chemical structure is different, which may result in improved pharmacokinetics and pharmacodynamics. Overall, AEPA is a promising candidate for the development of new cholesterol-lowering drugs. Further studies are needed to determine its safety and efficacy in humans, but its potential as a therapeutic agent is encouraging.

Additional Information

Packing Product will be supplied in Vials, in certain conditions we also use 'Septa Vials'
Controlled No
Parent API Atorvastatin
Therapeutic Anti-Diabetic
Smileys O=C(O)CC(O)CC1CCN2C(O)(C3=CC=C(F)C=C3)C4(C5=CC=CC=C5)OC4(C(NC6=CC=CC=C6)=O)C2(C(C)C)O1
Hazardous Yes

Need a Quote?

Your email address will not be published. Required fields are marked *

Safety & Handling Information

General Information Use proper personal protective equipment
Handling Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation.
Engineering Control Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels.
Clothing Wear appropriate protective clothing to minimize contact with skin.
Skin Wear appropriate protective gloves and clothing to prevent skin exposure.
Eyes Wear safety glasses and chemical goggles if splashing is possible.
Inhalation Remove from exposure and move to fresh air immediately.

What we promise?

  • 30-Days Money Back
  • Complete Documentation
  • Worldwide Delivery
  • Product Accuracy

Sample Label

logo Atorvastatin Epoxy P... www.clearsynth.com 
 CAT : CS-P-07053 BATCH : CSC-WWW0757

 MF: C₃₃H₃₅FN₂O₇
 CAS: 873950-17-5
 Date of Anaysis: 19-Aug-2023
 Retest Date: 19-Jun-2026
MW: 590.64

Store at refrigerator (2-8C)
Qty: 60 MG 
 Only for R & D and Analytical purpose, Not for Human Consumption.

Sample Packaging

Sample Packaging

Sample Vials

Sample Vials
Product List

Related Products